CV Sciences (CVSI) Gains from Investment Securities (2013 - 2025)

CV Sciences has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $40.9 million for Q3 2025.

• Gains from Investment Securities for Q3 2025 came in at $40.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $49000.0 (down 99.88% YoY), and the FY2025 annual result was $39.9 million, up 48.91% from the prior year.
• Gains from Investment Securities came in at $40.9 million for Q3 2025 at CV Sciences, down from $41.6 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $41.7 million in Q1 2025 to a low of -$504000.0 in Q3 2022.
• The 5-year median for Gains from Investment Securities is $4000.0 (2021), against an average of $9.4 million.
• Across the five-year window, Gains from Investment Securities sank 7100.0% in 2022 and surged 2684700.0% in 2024, its largest moves.
• CV Sciences' Gains from Investment Securities stood at -$25000.0 in 2021, then jumped by 136.0% to $9000.0 in 2022, then tumbled by 144.44% to -$4000.0 in 2023, then jumped by 1325.0% to $49000.0 in 2024, then surged by 83297.96% to $40.9 million in 2025.
• The last three Gains from Investment Securities figures came in at $40.9 million (Q3 2025), $41.6 million (Q2 2025), and $41.7 million (Q1 2025), per Business Quant data.